Company Analysis
Sign in

Teva Pharmaceutical Industries Limited (TEVA)

NYSE: TEVA · Pharmaceutical Preparations · Tel Aviv · filing with the SEC since 1996
Full chart Alerts Compare
Grade5.8
◀ Past 5.9● Present 6.3▶ Future 4.9
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

764 patents granted to the 20 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Teva Pharmaceutical Industries Limited’s names, not what it holds today.

Patents granted
764
720 utility, 38 design, 6 reissue, 1976 to Dec 31, 2025
Granted in 2025
1
Against 5 in 2024 and 9 in 2023
Applications published
879
20 of them in 2025
Names they are printed under
20
its own name, a subsidiary
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology20
Pharmaceuticals12
Organic fine chemistry10
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name20 counted
TEVA PHARMACEUTICAL INDUSTRIES, LTD. its own name
IL, as the owner printed on each patent
515 granted
354 published
TEVA PHARMACEUTICALS INTERNATIONAL GMBH a subsidiary
named as the applicant on its applications, in CH. 3 more under the same name are not counted (printed in CN, printed in US)
0 granted
138 published
ratiopharm GmbH a subsidiary
DE, as the owner printed on each patent
51 granted
77 published
Norton Healthcare Limited a subsidiary
GB, as the owner printed on each patent
72 granted
37 published
ACTAVIS GROUP PTC EHF a subsidiary
IS, as the owner printed on each patent. 1 more under the same name are not counted (printed in IE)
13 granted
64 published
TEVA PHARMACEUTICALS INTERNATIONAL GMBH a subsidiary
CH, as the owner printed on each patent. 1 more under the same name are not counted (printed in DE)
53 granted
20 published
Teva Pharmaceuticals USA, Inc. a subsidiary
US, as the owner printed on each patent
11 granted
48 published
RATIOPHARM GMBH a subsidiary
named as the applicant on its applications, in DE
0 granted
36 published
Merckle GmbH a subsidiary
DE, as the owner printed on each patent
26 granted
9 published
PLIVA HRVATSKA D.O.O. a subsidiary
HR, as the owner printed on each patent
13 granted
18 published
Teva Pharmaceutical Industries Ltd. its own name
named as the applicant on its applications, in IL
0 granted
21 published
NORTON HEALTHCARE LIMITED a subsidiary
named as the applicant on its applications, in GB
0 granted
19 published
TEVA CZECH INDUSTRIES S.R.O a subsidiary
named as the applicant on its applications, in CZ
0 granted
13 published
PLIVA HRVATSKA D.O.O. a subsidiary
named as the applicant on its applications, in HR
0 granted
11 published
Teva Sante a subsidiary
FR, as the owner printed on each patent
8 granted
1 published
Actavis Group PTC ehf a subsidiary
named as the applicant on its applications, in IS
0 granted
5 published
Teva UK Limited a subsidiary
GB, as the owner printed on each patent
1 granted
3 published
Teva Pharmaceuticals USA, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
3 published
TEVA CZECH INDUSTRIES S.R.O a subsidiary
CZ, as the owner printed on each patent
1 granted
1 published
Teva Sante a subsidiary
named as the applicant on its applications, in FR
0 granted
1 published
Names not counted (2)
Arrow International Limited
Most of its patents print US; this name counts in MT. 93 granted and 40 published under it are not counted.
Arrow International Limited
Most of its patents print US; this name counts in MT. 0 granted and 17 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
May 27, 202512,310,929Use of rasagiline for the treatment of restless legs syndromePharmaceuticalsTEVA PHARMACEUTICAL INDUSTRIES, LTD.
Dec 3, 202412,157,729Solid state forms of Belumosudil and Belumosudil saltsOrganic fine chemistryTEVA PHARMACEUTICALS INTERNATIONAL GMBH
Nov 26, 202412,151,086Injection deviceMedical technologyNorton Healthcare Limited
Nov 12, 202412,139,528Treating refractory migrainePharmaceuticalsTEVA PHARMACEUTICALS INTERNATIONAL GMBH
Sep 17, 202412,091,388Solid state forms of ReproxalapOrganic fine chemistryTEVA PHARMACEUTICALS INTERNATIONAL GMBH
Mar 26, 202411,938,298Medical injection device packagingMedical technologyTEVA PHARMACEUTICAL INDUSTRIES, LTD.
Nov 28, 202311,826,322Pre-filled syringeMedical technologyTeva Pharmaceuticals USA, Inc.
Nov 14, 202311,813,359Sustained release olanzapine formulationsPharmaceuticalsTEVA PHARMACEUTICALS INTERNATIONAL GMBH
Oct 3, 202311,773,083Solid state forms of Belumosudil and Belumosudil saltsOrganic fine chemistryTEVA PHARMACEUTICALS INTERNATIONAL GMBH
Oct 3, 202311,771,836Assembly for a medication delivery device and medication delivery deviceMedical technologyNorton Healthcare Limited
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Sep 4, 20252025/0276959SOLID STATE FORMS OF ZAVEGEPANT HYDROCHLORIDE AND PROCESS FOR PREPARATION THEREOFPharmaceuticalsTEVA CZECH INDUSTRIES S.R.O
Sep 4, 20252025/0275890VIAL ADAPTER AND VIAL ADAPTER SYSTEM AND METHODMedical technologyNorton Healthcare Limited
Aug 28, 20252025/0270184PROCESSES FOR THE PREPARATION OF FINERENONEOrganic fine chemistryTEVA PHARMACEUTICALS INTERNATIONAL GMBH
Aug 21, 20252025/0263474TREATING REFRACTORY MIGRAINEPharmaceuticalsTEVA PHARMACEUTICALS INTERNATIONAL GMBH
Aug 21, 20252025/0263380SOLID STATE FORMS OF MITAPIVAT AND PROCESS FOR PREPARATION THEREOFOrganic fine chemistryTEVA PHARMACEUTICALS INTERNATIONAL GMBH
Jul 24, 20252025/0236897PROCESSES FOR PREPARATION OF AVACOPAN AND INTERMEDIATES THEREOFBiotechnologyTEVA PHARMACEUTICALS INTERNATIONAL GMBH
Jul 24, 20252025/0236643SOLID STATE FORMS OF VOCLOSPORINPharmaceuticalsTEVA PHARMACEUTICALS INTERNATIONAL GMBH
Jun 19, 20252025/0197354SOLID STATE FORMS OF LX9211 AND SALTS THEREOFOrganic fine chemistryTEVA PHARMACEUTICALS INTERNATIONAL GMBH
May 29, 20252025/0171448SOLID STATE FORMS OF GUSACITINIBPharmaceuticalsTEVA PHARMACEUTICALS INTERNATIONAL GMBH
May 15, 20252025/0154158SOLID STATE FORMS OF SELTOREXANTOrganic fine chemistryTEVA CZECH INDUSTRIES S.R.O
What it applied for, 2024 to 2025: Organic fine chemistry 26 · Pharmaceuticals 12 · Medical technology 4 · Macromolecular chemistry, polymers 1 · Biotechnology 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton TEVA · research, not advice